A consensus report by the American Diabetes Association and European Association for the Study of Diabetes recommends GLP‐1 RA as second‐line therapy after metformin in individuals with Type 2 DM when choosing glucose‐lowering medication, particularly if there is a compelling need to minimize weight gain or promote weight loss.10 Here, GCG is linked to diabetes mellitus.